IT1036563B - Composizione per il trattamento ritaroato delle ferite apeerte contaminate - Google Patents

Composizione per il trattamento ritaroato delle ferite apeerte contaminate

Info

Publication number
IT1036563B
IT1036563B IT12415/75A IT1241575A IT1036563B IT 1036563 B IT1036563 B IT 1036563B IT 12415/75 A IT12415/75 A IT 12415/75A IT 1241575 A IT1241575 A IT 1241575A IT 1036563 B IT1036563 B IT 1036563B
Authority
IT
Italy
Prior art keywords
ritaroated
treatment
composition
open wounds
contaminated open
Prior art date
Application number
IT12415/75A
Other languages
English (en)
Original Assignee
Sutures Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sutures Inc filed Critical Sutures Inc
Application granted granted Critical
Publication of IT1036563B publication Critical patent/IT1036563B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21004—Trypsin (3.4.21.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT12415/75A 1974-04-29 1975-01-20 Composizione per il trattamento ritaroato delle ferite apeerte contaminate IT1036563B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/465,309 US3940478A (en) 1974-04-29 1974-04-29 Proteolytic enzymes as adjuncts to antibiotic prophylaxis of contaminated wounds

Publications (1)

Publication Number Publication Date
IT1036563B true IT1036563B (it) 1979-10-30

Family

ID=23847273

Family Applications (1)

Application Number Title Priority Date Filing Date
IT12415/75A IT1036563B (it) 1974-04-29 1975-01-20 Composizione per il trattamento ritaroato delle ferite apeerte contaminate

Country Status (4)

Country Link
US (1) US3940478A (it)
JP (1) JPS50140619A (it)
FR (1) FR2279421A1 (it)
IT (1) IT1036563B (it)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448903A1 (fr) * 1979-02-19 1980-09-12 Martin Henri Medicament nouveau a base d'agents antimicrobiens, d'enzymes, d'anti-inflammatoires, d'anesthesique local, d'agents keratolytiques, d'agents mucolytiques et d'au moins un emulsionnant
GB2150833B (en) * 1983-12-08 1987-04-15 Ceskoslovenska Akademie Ved Proteolytic wounds dressing
US5387517A (en) * 1994-03-23 1995-02-07 Ethicon, Inc. Thiol activated protease from stem bromelain for treating devitalized tissue
US5883074A (en) * 1995-02-08 1999-03-16 Microcide Pharmaceuticals, Inc. Potentiators of antibacterial agents
US6407056B1 (en) 1996-07-12 2002-06-18 Johnson & Johnson Consumer Companies, Inc. Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor
US6413512B1 (en) * 1998-02-13 2002-07-02 National Enzyme Company Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue
RU2145874C1 (ru) * 1998-12-07 2000-02-27 Сторожук Петр Григорьевич Способ получения некрэктомирующей повязки
US6187822B1 (en) * 1999-06-11 2001-02-13 University Of Medicine & Dentistry Of Nj Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
US6632429B1 (en) * 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
RU2191574C2 (ru) * 2000-03-13 2002-10-27 Открытое акционерное общество "Биосинтез" Лекарственное средство, обладающее регенерирующим и ранозаживляющим действием
US20070053895A1 (en) * 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US7048926B2 (en) * 2000-10-06 2006-05-23 Affinium Pharmaceuticals, Inc. Methods of agonizing and antagonizing FabK
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
RU2218167C2 (ru) * 2001-09-03 2003-12-10 Старцева Надежда Ивановна Способ получения композиционного средства - мази "свф"
US6861009B1 (en) * 2003-03-06 2005-03-01 E. Greg Leist Deicing compositions and methods of use
US20060169947A1 (en) * 2003-03-06 2006-08-03 Leist E G Deicing compositions and methods of use
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
US8021665B2 (en) * 2005-12-09 2011-09-20 Trius Therapeutics, Inc. Identification and application of antibiotic synergy
US7998476B2 (en) 2006-11-22 2011-08-16 Standard Biologics, Inc. Method of treatment using Aspergillus oryzae protease
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) * 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
WO2010002972A1 (en) * 2008-07-01 2010-01-07 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) * 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
JP5684725B2 (ja) * 2009-01-06 2015-03-18 キュレロン リミテッド ライアビリティ カンパニー 黄色ブドウ球菌感染の治療または予防のための組成物および方法ならびに表面上にいる黄色ブドウ球菌の根絶または低減のための組成物および方法
CA2747703C (en) 2009-01-06 2021-06-15 Curemark Llc Compositions and methods for the treatment or the prevention of infections by e. coli
AU2015252099B2 (en) * 2009-01-06 2017-08-10 Galenagen, Llc Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
GB2503852B (en) 2011-04-21 2018-12-12 Curemark Llc Compounds for the treatment of neuropsychiatric disorders
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
WO2018191233A1 (en) 2017-04-10 2018-10-18 Curemark, Llc Compositions for treating addiction
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2036E (fr) * 1903-04-29 1903-12-16 Moteurs Et Automobiles Herald Frein agissant dans les deux sens de marche, pour voitures automobiles et autres destinations
US2973300A (en) * 1956-05-07 1961-02-28 American Home Prod Process for making antibiotic-enzyme topical film-forming compositions

Also Published As

Publication number Publication date
FR2279421A1 (fr) 1976-02-20
FR2279421B1 (it) 1978-07-28
US3940478A (en) 1976-02-24
AU7788175A (en) 1976-08-05
JPS50140619A (it) 1975-11-11

Similar Documents

Publication Publication Date Title
IT1036563B (it) Composizione per il trattamento ritaroato delle ferite apeerte contaminate
DK215875A (da) Fremgangsmade til behandling af uonskede organismer med metaller
IT1062533B (it) Composizione per il trattamento di tessuti
BE824782A (fr) Compositions pour le traitement de gingivite
AT348111B (de) Orthopaedische einrichtung
IT1025275B (it) Composizione per il trattamento di tessuti
IT1026496B (it) Dispositivo per l assorbimento di rumdri
RO70493A (ro) Pansament steril pentru rani
SE7512274L (sv) Farmaceutisk komposition for topisk behandling av skinn
IT1039745B (it) Procedimento per la purificazione di eilende ossido
IT1041919B (it) Procedimento per il trattamento termico di rotaie
IT983488B (it) Composizione e procedimento per il trattamento delle acqu
IT1050758B (it) Disposizione per l applicazione di ingredienti
IT1031558B (it) Composizione per il trattamento di tessuti
IT1009777B (it) Procedimento integrale per il trattamento di acque inquinate
FR2307909A1 (fr) Compositions pour le traitement des etoffes
IT1041043B (it) Impianto di trattamento di bottiglie
IT1047830B (it) Impianto per il trattamento dell acqja
SE7609100L (sv) Hudbehandlingskomposition
SE7506293L (sv) Farmaceutiska kompositioner for behandling av hyperkolesterolemi.
IT7950138A0 (it) Composizione farmaceutica per il trattamento dei parkinsonismi
IT1027469B (it) Procedimento per lapreparazione di solfonil semicarbazidi
NO146142C (no) Fremgangsmaate for behandling av trefils
RO66137A (ro) Procedeu pentru prepararea clorhidratului de carnitina
IT1036928B (it) Procedimento per la preparazione di isoprene